Systematic review and meta-analysis of prospective studies for ECP treatment in patients with steroid-refractory acute GVHD

Patient Preference and Adherence

Volumn 9, Issue , 2015, Pages 105-111

  Zhang, Hongming ^a   Chen, Runzhe ^a   Cheng, Jian ^a   Jin, Nan ^a   Chen, Baoan ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Extracorporeal photopheresis; Steroid refractory acute graft versus host disease

Indexed keywords

STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE EXACERBATION; ENTEROPATHY; EVIDENCE BASED MEDICINE; EXTRACORPOREAL PHOTOPHERESIS; HUMAN; LIVER DISEASE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PHOTOTHERAPY; PROSPECTIVE STUDY; PUBLISHING; PUVA; SKIN DISEASE; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 84921631009     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S76563     Document Type: Article

References (23)

1. Bolaños-Meade J, Vogelsang GB. Novel strategies for steroid-refractory acute graft-versus-host disease. Curr Opin Hematol. 2005;12(1): 40–44.
2. Wolff D, Ayuk F, Elmaagacli A, et al. Current Practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers. Biol Blood Marrow Transplant. 2013;19(5):767–776.
3. Jagasia M, Arora M, Flowers ME, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012; 119(1):296–307.
4. Deeg HJ. How I treat refractory acute GVHD. Blood. 2007;109(10): 4119–4126.
5. Jagasia M, Greinix H, Robin M, et al. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Biol Blood Marrow Transplant. 2013;19(7):1129–1133.
6. Greinix HT, Volc-Platzer B, Kalhs P, et al. Extracorporeal photochemo-therapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood. 2000;96(7):2426–2431.
7. Bladon J, Taylor PC. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes. Br J Dermatol. 2002;146(1):59–68.
8. Chiesa-Fuxench ZC, González-Chávez J. Extracorporeal photopheresis: a review on the immunological aspects and clinical applications. P R Health Sci J. 2010;29(4):337–347.
9. Heshmati F. Mechanisms of action of extracorporeal photochemo-therapy. Transfus Apher Sci. 2003;29(1):61–70.
10. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341.
11. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Proceedings of the Third Symposium on Systematic Reviews Beyond the Basics: Improving Quality and Impact. 2010;7:3–5.
12. Smith EP, Sniecinski I, Dagis AC, et al. Extracorporeal photochemo-therapy for treatment of drug-resistant graft-vs-host disease. Biol Blood Marrow Transplant. 1998;4(1):27–37.
13. Salvaneschi L, Perotti C, Zecca M, et al. Extracorporeal photochemo-therapy for treatment of acute and chronic GVHD in childhood. Transfusion. 2001;41(10):1299–1305.
14. Garban F, Drillat P, Makowski C, et al. Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses. Haematologica. 2005;90(8):1096–1101.
15. Kanold J, Merlin E, Halle P, et al. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on feld experience and review of the literature. Transfusion. 2007;47(12):2276–2289.
16. Calore E, Calo A, Tridello G, et al. Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant. 2008;42(6):421–425.
17. Ussowicz M, Musiał J, Mielcarek M, et al. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplant Proc. 2013;45(9):3375–3380.
18. Greinix HT, Knobler RM, Worel N, et al. The effect of intensifed extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica. 2006;91(3):405–408.
19. Abu-Dalle I, Reljic T, Nishihori T, et al. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies. Biol Blood Marrow Transplant. 2014;20(11):1677–1686.
20. Malik MI, Litzow M, Hogan W, et al. Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis. Blood Res. 2014;49(2):100–106.
21. Taverna F, Coluccia P, Arienti F, et al. Biological quality control for extracorporeal photochemotherapy: assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients. J Clin Apher. Epub 2014 Sep 16.
22. Garban F, Carras S, Drillat P, et al. Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia. Ann Oncol. 2012;23(9):2386–2390.
23. Perfetti P, Carlier P, Strada P, et al. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant. 2008;42(9):609–617.